FDA Inspection
Regenerative Biologics Inc.Regenerative Biologics Inc. – FDA Inspection, May 1, 2013
Record Details
This FDA Inspection record concerns Regenerative Biologics Inc., with an inspection on May 1, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Regenerative Biologics Inc.
- Inspection Date
- May 1, 2013
- Product Type
- Biologics
View Company Profile
ID · f65fcbac-8b9d-4aa2-8ff6-b0ef3c191328
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 829271
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.160(b)(4)Training of personnel
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Regenerative Biologics Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2025 | Not classified | Florida District Office | |
| April 13, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 6, 2020 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 16, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Regenerative Biologics Inc.
- FDA Inspection 1293608 - 2025-11-18
- FDA Inspection 1202949 - 2023-04-13
- FDA Inspection 1117126 - 2020-02-06
- FDA Inspection 1026631 - 2017-08-15
- FDA Inspection 922553 - 2015-04-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.